Hepatic progenitor cells: Another piece in the nonalcoholic fatty liver disease puzzle†‡§
See Article on Page 2142
Potential conflict of interest: S.A.H.: Research support: Rottapharm, Mochida. Ad hoc advisory board: Amylin Pharmaceuticals.
Disclaimer: The view(s) expressed herein are those of the author(s) and do not reflect the official policy or position of Brooke Army Medical Center, the U.S. Army Medical Department, the U.S. Army Office of the Surgeon General, the Department of the Army, Department of Defense or the U.S. Government.
No abstract is available for this article.